Hypersomnolence, Hypersomnia, and Mood Disorders

Current Psychiatry Reports

Volumn 19, Issue 2, 2017, Pages

  Barateau, Lucie ^a,b,c   Lopez, Régis ^a,b,c   Franchi, Jean Arthur Micoulaud ^d,e,f   Dauvilliers, Yves ^a,b,c  

^a GUI DE CHAULIAC HOSPITAL   (France)

^b Sleep Disorders Center   (France)

^c INSERM U1061   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f CNRS   (France)

Author keywords

Depression; Excessive daytime sleepiness; Hypersomnia; Hypersomnolence; Idiopathic hypersomnia; Mood; Narcolepsy type 1; Narcolepsy type 2; Psychiatric disorders

Indexed keywords

ACTIMETRY; BIPOLAR DISORDER; CLINICAL ASSESSMENT; COMORBIDITY; DISEASE ASSOCIATION; HUMAN; HYPERSOMNIA; MAINTENANCE OF WAKEFULNESS TEST; MAJOR DEPRESSION; MOOD DISORDER; MULTIPLE SLEEP LATENCY TEST; NARCOLEPSY; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; REVIEW; SEASONAL AFFECTIVE DISORDER; SLEEP DISORDER ASSESSMENT; SLEEP PATTERN; SLEEP QUALITY; SOMNOLENCE; DEPRESSIVE DISORDER, MAJOR; DIFFERENTIAL DIAGNOSIS; DISORDERS OF EXCESSIVE SOMNOLENCE; HYPERSOMNOLENCE, IDIOPATHIC; INTERDISCIPLINARY COMMUNICATION; INTERSECTORAL COLLABORATION; MENTAL DISORDERS; PSYCHIATRY; PSYCHOLOGY; SLEEP APNEA SYNDROMES;

COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; DISORDERS OF EXCESSIVE SOMNOLENCE; HUMANS; HYPERSOMNOLENCE, IDIOPATHIC; INTERDISCIPLINARY COMMUNICATION; INTERSECTORAL COLLABORATION; MENTAL DISORDERS; NARCOLEPSY; POLYSOMNOGRAPHY; PSYCHIATRY; SLEEP APNEA SYNDROMES;

EID: 85014035286     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-017-0763-0     Document Type: Review

References (86)

1. • Dauvilliers Y, Lopez R, Ohayon M, Bayard S. Hypersomnia and depressive symptoms: methodological and clinical aspects. BMC Med. 2013;11:78. A comprehensive review on hypersomnolence and psychiatric disorders.
2. Bassetti CL, Ferini-Strambi L, Brown S, Adamantidis A, Benedetti F, Bruni O, et al. Neurology and psychiatry: waking up to opportunities of sleep: state of the art and clinical/research priorities for the next decade. Eur J Neurol. 2015;22:1337–54.
3. • Ohayon MM, Dauvilliers Y, Reynolds CF. Operational definitions and algorithms for excessive sleepiness in the general population: implications for DSM-5 nosology. Arch Gen Psychiatry. 2012;69:71–9. A large survey in the adult US general population showed that excessive sleepiness is a highly underestimated prevalent problem.
4. Kaplan KA, Harvey AG. Hypersomnia across mood disorders: a review and synthesis. Sleep Med Rev. 2009;13:275–85.
5. Pallesen S, Nordhus IH, Omvik S, Sivertsen B, Tell GS, Bjorvatn B. Prevalence and risk factors of subjective sleepiness in the general adult population. Sleep. 2007;30:619–24.
6. Jaussent I, Bouyer J, Ancelin M-L, Akbaraly T, Pérès K, Ritchie K, et al. Insomnia and daytime sleepiness are risk factors for depressive symptoms in the elderly. Sleep. 2011;34:1103–10.
7. • Plante DT. Sleep propensity in psychiatric hypersomnolence: a systematic review and meta-analysis of multiple sleep latency test findings. Sleep Med. Rev. 2016;31:48–57. A comprehensive review and meta-analysis of objective sleepiness in psychiatric conditions.
8. AASM: The international classification of sleep disorders, third edition: diagnostic and coding manual (ICSD-3). Darien, IL: American Academy of Sleep Medicine. 2014.
9. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, 5th ed (DSM-5). APA. Arlington, VA: 2013.
10. Bassetti CL, Dauvilliers Y: Idiopathic hypersomnia, 969–989. In Principles and Practice of Sleep Medicine. 5th edition. Edited by Kryger MH, Roth T, Dement WC ED. Elsevier Saunders; 2011.
11. Billiard M, Dauvilliers Y. Idiopathic hypersomnia. Sleep Med Rev. 2001;5:349–58.
12. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5.
13. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. Quantification of sleepiness: a new approach. Psychophysiology. 1973;10:431–6.
14. Akerstedt T, Gillberg M. Subjective and objective sleepiness in the active individual. Int J Neurosci. 1990;52:29–37.
15. Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a standard research assessment of insomnia. Sleep. 2006;29:1155–73.
16. Martin JL, Hakim AD. Wrist actigraphy. Chest. 2011;139:1514–27.
17. Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep. 2007;30:519–29.
18. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 2003;26:342–92.
19. Billiard M. Idiopathic hypersomnia. Neurol Clin. 1996;14:573–82.
20. Vernet C, Arnulf I. Idiopathic hypersomnia with and without long sleep time: a controlled series of 75 patients. Sleep. 2009;32:753–9.
21. Arand D, Bonnet M, Hurwitz T, Mitler M, Rosa R, Sangal RB. The clinical use of the MSLT and MWT. Sleep. 2005;28:123–44.
22. Littner MR, Kushida C, Wise M, Davila DG, Morgenthaler T, Lee-Chiong T, et al. Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep. 2005;28:113–21.
23. Doghramji K, Mitler MM, Sangal RB, Shapiro C, Taylor S, Walsleben J, et al. A normative study of the maintenance of wakefulness test (MWT). Electroencephalogr Clin Neurophysiol. 1997;103:554–62.
24. Zimmerman M, McGlinchey JB, Posternak MA, Friedman M, Boerescu D, Attiullah N. Differences between minimally depressed patients who do and do not consider themselves to be in remission. J Clin Psychiatry. 2005;66:1134–8.
25. Fitzgerald CT, Messias E, Buysse DJ. Teen sleep and suicidality: results from the youth risk behavior surveys of 2007 and 2009. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2011;7:351–6.
26. Goldstein TR, Bridge JA, Brent DA. Sleep disturbance preceding completed suicide in adolescents. J Consult Clin Psychol. 2008;76:84–91.
27. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, et al. Development of a fatigue scale. J Psychosom Res. 1993;37:147–53.
28. Monteleone P, Maj M. The circadian basis of mood disorders: recent developments and treatment implications. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol. 2008;18:701–11.
29. Sørensen MJ, Nissen JB, Mors O, Thomsen PH. Age and gender differences in depressive symptomatology and comorbidity: an incident sample of psychiatrically admitted children. J Affect Disord. 2005;84:85–91.
30. Roberts RE, Shema SJ, Kaplan GA, Strawbridge WJ. Sleep complaints and depression in an aging cohort: a prospective perspective. Am J Psychiatry. 2000;157:81–8.
31. Akiskal HS, Benazzi F. Atypical depression: a variant of bipolar II or a bridge between unipolar and bipolar II? J Affect Disord. 2005;84:209–17.
32. Williamson DE, Birmaher B, Brent DA, Balach L, Dahl RE, Ryan ND. Atypical symptoms of depression in a sample of depressed child and adolescent outpatients. J Am Acad Child Adolesc Psychiatry. 2000;39:1253–9.
33. Kaplan KA, Gruber J, Eidelman P, Talbot LS, Harvey AG. Hypersomnia in inter-episode bipolar disorder: does it have prognostic significance? J Affect Disord. 2011;132:438–44.
34. Tsuno N, Jaussent I, Dauvilliers Y, Touchon J, Ritchie K, Besset A. Determinants of excessive daytime sleepiness in a French community-dwelling elderly population. J Sleep Res. 2007;16:364–71.
35. Allen JM, Lam RW, Remick RA, Sadovnick AD. Depressive symptoms and family history in seasonal and nonseasonal mood disorders. Am J Psychiatry. 1993;150:443–8.
36. Terman M, Amira L, Terman JS, Ross DC. Predictors of response and nonresponse to light treatment for winter depression. Am J Psychiatry. 1996;153:1423–9.
37. Winkler D, Willeit M, Praschak-Rieder N, Lucht MJ, Hilger E, Konstantinidis A, et al. Changes of clinical pattern in seasonal affective disorder (SAD) over time in a German-speaking sample. Eur Arch Psychiatry Clin Neurosci. 2002;252:54–62.
38. Avery DH, Khan A, Dager SR, Cohen S, Cox GB, Dunner DL. Morning or evening bright light treatment of winter depression? The significance of hypersomnia. Biol Psychiatry. 1991;29:117–26.
39. Tam EM, Lam RW, Robertson HA, Stewart JN, Yatham LN, Zis AP. Atypical depressive symptoms in seasonal and non-seasonal mood disorders. J Affect Disord. 1997;44:39–44.
40. Trotti LM. Waking up is the hardest thing I do all day: Sleep inertia and sleep drunkenness. Sleep Med Rev. 2016;Sep 4 Epub.
41. Nofzinger EA, Thase ME, Reynolds CF, Himmelhoch JM, Mallinger A, Houck P, et al. Hypersomnia in bipolar depression: a comparison with narcolepsy using the multiple sleep latency test. Am J Psychiatry. 1991;148:1177–81.
42. Billiard M, Partinen M, Roth T, Shapiro C. Sleep and psychiatric disorders. J Psychosom Res. 1994;38 Suppl 1:1–2.
43. Dolenc L, Besset A, Billiard M. Hypersomnia in association with dysthymia in comparison with idiopathic hypersomnia and normal controls. Pflüg Arch Eur J Physiol. 1996;431:R303–4.
44. Vgontzas AN, Bixler EO, Kales A, Criley C, Vela-Bueno A. Differences in nocturnal and daytime sleep between primary and psychiatric hypersomnia: diagnostic and treatment implications. Psychosom Med. 2000;62:220–6.
45. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989;262:1479–84.
46. Staner L. Comorbidity of insomnia and depression. Sleep Med Rev. 2010;14:35–46.
47. Rao U, Hammen CL, Poland RE. Risk markers for depression in adolescents: sleep and HPA measures. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol. 2009;34:1936–45.
48. Manber R, Haynes T, Siebern AT: Sleep and Psychiatry Disorders, 471–501 In The Oxford Handbook of Sleep and Sleep Disorders. 1st edition. Edited by Morin CM, Espie CA. Oxford University Press; 2012.
49. Baglioni C, Nanovska S, Regen W, Spiegelhalder K, Feige B, Nissen C, et al. Sleep and Mental Disorders: A Meta-Analysis of Polysomnographic Research. Psychol Bull. 2016;142:960-90.
50. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999;131:485–91.
51. Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology. 2008;108:812–21.
52. Stubbs B, Vancampfort D, Veronese N, Solmi M, Gaughran F, Manu P, et al. The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: a systematic review and meta-analysis. J Affect Disord. 2016;197:259–67.
53. Plante DT, Winkelman JW. Sleep disturbance in bipolar disorder: therapeutic implications. Am J Psychiatry. 2008;165:830–43.
54. Rishi MA, Shetty M, Wolff A, Amoateng-Adjepong Y, Manthous CA. Atypical antipsychotic medications are independently associated with severe obstructive sleep apnea. Clin Neuropharmacol. 2010;33:109–13.
55. Mignot E, Lin L, Finn L, Lopes C, Pluff K, Sundstrom ML, et al. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain J Neurol. 2006;129:1609–23.
56. Goldbart A, Peppard P, Finn L, Ruoff CM, Barnet J, Young T, et al. Narcolepsy and predictors of positive MSLTs in the Wisconsin Sleep Cohort. Sleep. 2014;37:1043–51.
57. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet. 2007;369:499–511.
58. Scammell TE. Narcolepsy. N Engl J Med. 2015;373:2654–62.
59. Dauvilliers Y, Billiard M, Montplaisir J. Clinical aspects and pathophysiology of narcolepsy. Clin Neurophysiol. 2003;114:2000–17.
60. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci. 2007;8:171–81.
61. Scott MM, Marcus JN, Pettersen A, Birnbaum SG, Mochizuki T, Scammell TE, et al. Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behav Brain Res. 2011;222:289–94.
62. Fortuyn HAD, Mulders PC, Renier WO, Buitelaar JK, Overeem S. Narcolepsy and psychiatry: an evolving association of increasing interest. Sleep Med. 2011;12:714–9.
63. Dauvilliers Y, Gaig C, Barateau L, Graus F, Iranzo A, Lopez R, et al. Absence of NMDA receptor antibodies in the rare association between type 1 narcolepsy and psychosis. Sci Rep. 2016;6:25230.
64. Lecendreux M, Lavault S, Lopez R, Inocente CO, Konofal E, Cortese S, et al. Attention-deficit/hyperactivity disorder (ADHD) symptoms in pediatric narcolepsy: a cross-sectional study. Sleep. 2015;38:1285–95.
65. Roy A. Psychiatric aspects of narcolepsy. Br J Psychiatry J Ment Sci. 1976;128:562–5.
66. Krishnan RR, Volow MR, Miller PP, Carwile ST. Narcolepsy: preliminary retrospective study of psychiatric and psychosocial aspects. Am J Psychiatry. 1984;141:428–31.
67. Kales A, Soldatos CR, Bixler EO, Caldwell A, Cadieux RJ, Verrechio JM, et al. Narcolepsy-cataplexy. II. Psychosocial consequences and associated psychopathology. Arch Neurol. 1982;39:169–71.
68. Mosko S, Zetin M, Glen S, Garber D, DeAntonio M, Sassin J, et al. Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients. J Clin Psychol. 1989;45:51–60.
69. Vourdas A, Shneerson JM, Gregory CA, Smith IE, King MA, Morrish E, et al. Narcolepsy and psychopathology: is there an association? Sleep Med. 2002;3:353–60.
70. Fortuyn HAD, Lappenschaar MA, Furer JW, Hodiamont PP, Rijnders CAT, Renier WO, et al. Anxiety and mood disorders in narcolepsy: a case-control study. Gen Hosp Psychiatry. 2010;32:49–56.
71. Dauvilliers Y, Paquereau J, Bastuji H, Drouot X, Weil J-S, Viot-Blanc V. Psychological health in central hypersomnias: the French Harmony study. J Neurol Neurosurg Psychiatry. 2009;80:636–41.
72. Vandeputte M, de Weerd A. Sleep disorders and depressive feelings: a global survey with the Beck depression scale. Sleep Med. 2003;4:343–5.
73. Vignatelli L, Plazzi G, Peschechera F, Delaj L, D’Alessandro R. A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy. Sleep Med. 2011;12:19–23.
74. Bassetti C, Aldrich MS. Idiopathic hypersomnia. A series of 42 patients. Brain J. Neurol. 1997;120(Pt 8):1423–35.
75. Roth B, Nevsimalova S. Depresssion in narcolepsy and hypersommia. Schweiz Arch Für Neurol Neurochir Psychiatr Arch Suisses Neurol Neurochir Psychiatr. 1975;116:291–300.
76. Arnulf I, Rico TJ, Mignot E. Diagnosis, disease course, and management of patients with Kleine-Levin syndrome. Lancet Neurol. 2012;11:918–28.
77. Dauvilliers Y, Lopez R. Time to find a biomarker in Kleine-Levin Syndrome. Sleep Med. 2016;21:177.
78. Worthington J, Fava M, Davidson K, Alpert J, Nierenberg AA, Rosenbaum JF. Patterns of improvement in depressive symptoms with fluoxetine treatment. Psychopharmacol Bull. 1995;31:223–6.
79. Geoffroy PA, Scott J, Boudebesse C, Lajnef M, Henry C, Leboyer M, et al. Sleep in patients with remitted bipolar disorders: a meta-analysis of actigraphy studies. Acta Psychiatr Scand. 2015;131:89–99.
80. Geoffroy PA, Etain B, Franchi J-AM, Bellivier F, Ritter P. Melatonin and melatonin agonists as adjunctive treatments in bipolar disorders. Curr Pharm Des. 2015;21:3352–8.
81. Dauvilliers Y, Baumann CR, Carlander B, Bischof M, Blatter T, Lecendreux M, Mali F, Besset A, Touchon J, Billiard M, Tafti M, Bassetti CL. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. J Neurol Neurosurg Psychiatry. 2003;74:1667–73.
82. Gelperin K, Phelan K. Psychiatric adverse events associated with drug treatment of ADHD: review of postmarketing safety data. FDA Report PID D050243. US Food and Drug Administration, March 3, 2006. 2008.
83. Calabrese JR, Ketter TA, Youakim JM, Tiller JM, Yang R, Frye MA. Adjunctive armodafinil for major depressive episodes associated with bipolar I disorder: a randomized, multicenter, double-blind, placebo-controlled, proof-of-concept study. J Clin Psychiatry. 2010;71:1363–70.
84. Frye MA, Grunze H, Suppes T, McElroy SL, Keck PE, Walden J, et al. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression. Am J Psychiatry. 2007;164:1242–9.
85. Auger RR, Goodman SH, Silber MH, Krahn LE, Pankratz VS, Slocumb NL. Risks of high-dose stimulants in the treatment of disorders of excessive somnolence: a case-control study. Sleep. 2005;28:667–72.
86. • Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol. 2013;12:1068–75. This study reports the results of a new drug (pitolisant) of interest to treat patients with narcolepsy with potential for other hypersomnia conditions.